Back to
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
ABUS6 quarters
Position history for
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in ARBUTUS BIOPHARMA CORP
Yes. Arrowstreet Capital holds 650,700 shares of ABUS (Arbutus Biopharma), worth $3.1M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$3.1M
Current Shares
650,700
Total Value Change
+$3M
Total Shares Change
+588,379
Quarter-by-Quarter History
Other major holders of ABUS: MORGAN STANLEY